1. Home
  2. Southern Africa
  3. South Africa

Concerns raised about Nevirapine report

A media report saying research had found that pregnant women using the anti-AIDS drug, Nevirapine, could develop resistance to future use of HIV/AIDS drugs, has raised concern in South Africa.

The findings were presented at the 11th Annual Retrovirus Conference, held recently in San Francisco in the US.

According to BuaNews, a local news service, Nevirapine was currently being used in the government's national programme for the prevention of mother-to-child transmission (PMTCT) of HIV at 18 pilot sites.

Health Minister Manto Tshabalala-Msimang responded by saying she had referred these concerns to the Medicines Control Council (MCC) for investigation as soon as possible, and would be advised of their findings.


This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join